Multisystem Inflammatory Syndrome in Children in Western Countries? Decreasing Incidence as the Pandemic Progresses?: An Observational Multicenter International Cross-sectional Study

Altres autors/es

[Buonsenso D] From the Department of Woman and Child Health and Public Health, Fondazione Policlnico Universitario A. Gemelli IRCCS, Rome, Italy. Centro di Salute Globale, Università Cattolica del Sacro Cuore, Roma, Italy. [Perramon A] Department of Physics, Universitat Politècnica de Catalunya (UPC·BarcelonaTech), Barcelona, Catalonia, Spain. [Català M] Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, United Kingdom. [Torres JP] Department of Paediatrics, Division of Paediatric Infectious Diseases, Hospital Luis Calvo Mackenna, Faculty of Medicine, Universidad de Chile, Santiago de Chile, Chile. [Camacho-Moreno G] Paediatric Infectious Diseases Unit, HOMI, Fundación Hospital Pediátrico la Misericordia, Universidad Nacional de Colombia, Bogotá, Colombia. [Rojas-Solano M] Unidad de Vigilancia Epidemiológica. [Martínez-Mejias A] Servei de Pediatria, Hospital de Terrassa, Consorci Sanitari de Terrassa, Terrassa, Spain

Consorci Sanitari de Terrassa

Data de publicació

2023-08-02T10:59:36Z

2023-08-02T10:59:36Z

2022-12-01



Resum

COVID-19, Multisystemic inflammatory syndrome; Children; Epidemiology


COVID-19, Síndrome inflamatorio multisistémico; Niños; Epidemiología


COVID-19, Síndrome inflamatòria multisistèmica; Nens; Epidemiologia


Background: SARS-CoV-2 variations as well as immune protection after previous infections and/or vaccination may have altered the incidence of multisystemic inflammatory syndrome in children (MIS-C). We aimed to report an international time-series analysis of the incidence of MIS-C to determine if there was a shift in the regions or countries included into the study. Methods: This is a multicenter, international, cross-sectional study. We collected the MIS-C incidence from the participant regions and countries for the period July 2020 to November 2021. We assessed the ratio between MIS-C cases and COVID-19 pediatric cases in children <18 years diagnosed 4 weeks earlier (average time for the temporal association observed in this disease) for the study period. We performed a binomial regression analysis for 8 participating sites [Bogotá (Colombia), Chile, Costa Rica, Lazio (Italy), Mexico DF, Panama, The Netherlands and Catalonia (Spain)]. Results: We included 904 cases of MIS-C, among a reference population of 17,906,432 children. We estimated a global significant decrease trend ratio in MIS-C cases/COVID-19 diagnosed cases in the previous month ( P < 0.001). When analyzing separately each of the sites, Chile and The Netherlands maintained a significant decrease trend ( P < 0.001), but this ratio was not statistically significant for the rest of sites. Conclusions: To our knowledge, this is the first international study describing a global reduction in the trend of the MIS-C incidence during the pandemic. COVID-19 vaccination and other factors possibly linked to the virus itself and/or community transmission may have played a role in preventing new MIS-C cases.

Tipus de document

Article


Versió publicada

Llengua

Anglès

Publicat per

Lippincott, Williams & Wilkins

Documents relacionats

The Pediatric Infectious Disease Journal;41(12)

https://doi.org/10.1097/inf.0000000000003713

Citació recomanada

Aquesta citació s'ha generat automàticament.

Drets

Attribution-NonCommercial-NoDerivatives 4.0 International

http://creativecommons.org/licenses/by-nc-nd/4.0/

Aquest element apareix en la col·lecció o col·leccions següent(s)